Patents by Inventor Rukiyah T. Van Dross

Rukiyah T. Van Dross has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds, compositions, kits, and methods for activating immune cells and/or an immune system response
    Patent number: 11571401
    Abstract: Provided is a method of activating immune cells and/or an immune system response in a subject. The method may comprise administering to a subject an effective amount of a compound of Formula (I): or a prodrug, derivative, and/or salt thereof. In some embodiments, the method comprises contacting an immune cell with a compound of Formula (I) or a prodrug, derivative, and/or salt thereof. Also provided are compounds, compositions, and kits for activating immune cells and/or an immune system response in a subject.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: February 7, 2023
    Assignee: East Carolina University
    Inventors: Rukiyah T. Van Dross-Anderson, Rene Escobedo
  • J-SERIES PROSTAGLANDIN-ETHANOLAMIDES AS NOVEL THERAPEUTICS FOR SKIN AND/OR ORAL DISORDERS
    Publication number: 20210177864
    Abstract: Provided is a method of preventing and/or treating a skin disorder and/or an oral disorder including administering to a subject in need thereof an effective amount of a compound of formula (I): or a prodrug or derivative thereof, and salts thereof.
    Type: Application
    Filed: February 24, 2021
    Publication date: June 17, 2021
    Inventor: Rukiyah T. Van Dross
  • J-series prostaglandin-ethanolamides as novel therapeutics for skin and/or oral disorders
    Patent number: 10960013
    Abstract: Provided is a method of preventing and/or treating a skin disorder and/or an oral disorder including administering to a subject in need thereof an effective amount of a compound of formula (I) or a prodrug or derivative thereof, and salts thereof.
    Type: Grant
    Filed: March 2, 2017
    Date of Patent: March 30, 2021
    Assignee: East Carolina University
    Inventor: Rukiyah T. Van Dross
  • COMPOUNDS, COMPOSITIONS, KITS, AND METHODS FOR ACTIVATING IMMUNE CELLS AND/OR AN IMMUNE SYSTEM RESPONSE
    Publication number: 20200306212
    Abstract: Provided is a method of activating immune cells and/or an immune system response in a subject. The method may comprise administering to a subject an effective amount of a compound of Formula (I): or a prodrug, derivative, and/or salt thereof. In some embodiments, the method comprises contacting an immune cell with a compound of Formula (I) or a prodrug, derivative, and/or salt thereof. Also provided are compounds, compositions, and kits for activating immune cells and/or an immune system response in a subject.
    Type: Application
    Filed: August 30, 2018
    Publication date: October 1, 2020
    Inventors: Rukiyah T. Van Dross-Anderson, Rene Escobedo
  • J-SERIES PROSTAGLANDIN-ETHANOLAMIDES AS NOVEL THERAPEUTICS FOR SKIN AND/OR ORAL DISORDERS
    Publication number: 20190091238
    Abstract: Provided is a method of preventing and/or treating a skin disorder and/or an oral disorder including administering to a subject in need thereof an effective amount of a compound of formula (I) or a prodrug or derivative thereof, and salts thereof.
    Type: Application
    Filed: March 2, 2017
    Publication date: March 28, 2019
    Inventor: Rukiyah T. Van Dross
  • J-series prostaglandin-ethanolamides as novel therapeutics
    Patent number: 9328060
    Abstract: Provided is a compound of formula (I): a pharmaceutical composition comprising the compound of formula (I), a pharmaceutical composition comprising anandamide (AEA) and methods of using the same in the treatment of non-melanoma skin cancer (NMSC) and colorectal cancer.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: May 3, 2016
    Assignee: East Carolina University
    Inventors: Rukiyah T. Van Dross, Daniel A. Ladin, Colin S. Burns, Allison Stokes Danell
  • J-SERIES PROSTAGLANDIN-ETHANOLAMIDES AS NOVEL THERAPEUTICS
    Publication number: 20150111969
    Abstract: Provided is a compound of formula (I): a pharmaceutical composition comprising the compound of formula (I), a pharmaceutical composition comprising anandamide (AEA) and methods of using the same in the treatment of non-melanoma skin cancer (NMSC) and colorectal cancer.
    Type: Application
    Filed: October 17, 2014
    Publication date: April 23, 2015
    Inventors: Rukiyah T. Van Dross, Daniel A. Ladin, Colin S. Burns, Allison Stokes Danell